D Turci

Department of Oncology and Hematology Santa Maria delle Croci Hospital

关注

立即认领

关注

立即认领

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 55 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

MA 02.05 Nivolumab in Advanced Non-Squamous NSCLC Patients with KRAS Mutations: Results from the Italian Expanded Access Program (EAP)

A. Ardizzoni,P. Bidoli,R. Chiari,L. Bonomi,D. Turci,L. Landi,L. Toschi,M. De Tursi,G. Francini, M. Giordano,O. Alabiso,A. De Censi,L. Livi,A. Berruti, M. Minelli,E. Ricevuto,A. Illiano,G. Puppo,A. Delmonte,D. Galetta

Journal of thoracic oncology（2017）

引用2浏览0引用

Negative Prognostic Factors and Resulting Clinical Outcome in Patients (pts) with Metastatic Renal Cell Carcinoma (mrcc) Included in the Italian Nivolumab Expanded Access Program (Eap)

S. Bracarda,L. Galli,M. Maruzzo,G. Lo Re,S. Buti,A. Favaretto,F. D. Costanzo,C. Sacco,M. Merlano,C. Mucciarini,E. Zafarana,S. Romito,A. Maestri, C. Giannitto Giorgio,M. T. Ionta,D. Turci,U. De Giorgi,G. Procopio,E. Cortesi,C. Porta

Annals of oncology（2017）

引用0浏览0引用

Italian Nivolumab Expanded Access Programme in Non-Squamous Non-Small Cell Lung Cancer Patients: Real-world Results in Never Smokers and EGFR Positive Patients

M. C. Garassino,E. Cortesi,F. Grossi,R. Chiari,H. J. Soto Parra,S. Cascinu,F. Cognetti,D. Turci,L. Blasi,C. Bengala, E. Mini,E. E. Baldini,T. Gamucci,G. L. Ceresoli,P. Antonelli,E. Vasile,M. Pagano,M. Macerelli, A. Lagroscino,F. De Marinis

Annals of oncology（2017）

引用2浏览0引用

Germline Variants and Clinical Outcomes of High-Risk Stage II and Stage III Colon Cancer Patients Treated with Oxaliplatin and Fluoropyrimidines Adjuvant Chemotherapy: a Pharmacogenetic Ancillary Study to TOSCA Trial

A. Ruzzo,F. Galli,E. Rulli,S. Lonardi,V. Zagonel,M. Ronzoni,M. T. Ionta,N. Pella,C. Mucciarini,R. Labianca,E. Veltri,P. Sozzi,S. Barni,M. Nicolini,E. Biondi, A. Bramati,D. Turci,M. Buscaglia,M. Magnani,F. Graziano

Annals of oncology（2017）

引用0浏览0WOS引用

Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients

A Ruzzo,F Graziano,Fabio Galli,Francesca Galli,E Rulli,S Lonardi,M Ronzoni,B Massidda,V Zagonel,N Pella,C Mucciarini,R Labianca,M T Ionta,I Bagaloni,E Veltri,P Sozzi,S Barni,V Ricci,L Foltran,M Nicolini,E Biondi, A Bramati,D Turci,S Lazzarelli,C Verusio,F Bergamo,A Sobrero,L Frontini, M Menghi,M Magnani

BRITISH JOURNAL OF CANCER（2017）

引用44浏览0WOSNATURE引用

MA 11.11 Italian Nivolumab Expanded Access Program in Non-Squamous NSCLC Patients: Results in Never Smokers and EGFR Positive Patients

M. Garassino,E. Cortesi,F. Grossi,R. Chiari,H. Soto Parra,S. Cascinu,F. Cognetti,D. Turci,L. Blasi,C. Bengala,E. Mini,E. Baldini,T. Gamucci,G. Ceresoli,P. Antonelli,E. Vasile,C. Pinto,D. Galetta,M. Macerelli,F. De Marinis

Journal of thoracic oncology（2017）

引用1浏览0引用

Italian Nivolumab Expanded Access Programme: Real-World Results In Non-Squamous Non-Small Cell Lung Cancer Patients

F. Grossi,L. Crino,A. Delmonte,D. Turci,G. Lo Russo,F. De Marinis,H. J. Soto Parra,D. Galetta,F. Cappuzzo,F. Sperandi,M. Tiseo,G. Puppo,F. Roila,M. R. Migliorino,G. Tonini,F. Cognetti,A. Santoro,D. Tassinari,A. Scoppola,E. Cortesi

ANNALS OF ONCOLOGY (2017)

引用2浏览0引用

Real Life Experience with Nivolumab in Patients (pts) with Advanced Non-Squamous NSCLC (Nsq-Nsclc) Exhibiting KRAS Mutations: the Italian Expanded Access Program (EAP)

F. Cappuzzo,P. Bidoli,R. Chiari, A. Chirco,D. Turci,A. Ardizzoni,A. Santoro,C. Natoli,G. Francini,M. Giordano,G. Borra,C. Defferrari,L. Livi,A. Berruti, M. Minelli,E. Ricevuto,A. Illiano,G. Puppo,A. Delmonte,A. Misino

Annals of oncology（2017）

引用0浏览0引用

Use of Nivolumab in Elderly Patients with Advanced Non-Squamous NSCLC: Results from the Italian Expanded Access Program (EAP)

M. R. Migliorino,A. Gelibter,F. Grossi,D. Fagnani,P. Bordi,T. Franchina,D. Turci,L. Di Lauro,S. Cascinu,L. Calabro,M. Brighenti,N. Tedde,A. Bearz, S. Giusti,E. Vasile,G. Surico,G. Carteni, P. Marchetti,F. Verderame,B. Melotti

Annals of oncology（2017）

引用10浏览0引用

Efficacy and Safety of Nivolumab in Elderly Patients (pts) with Advanced Squamous Non Small Cell Lung Cancer (Sq-Nsclc) Participating in the Expanded Access Programme (EAP) in Italy

F. Grossi,L. Crino,A. Misino,P. Bidoli,A. Delmonte,F. Gelsomino,C. Proto,M. Mancini,L. Landi,D. Turci,S. Quadrini,P. Antonelli,P. Marchetti,L. Toschi,S. Giusti,F. Di Costanzo,F. Rastelli,P. Sandri,V. Scotti,F. de Marinis

Annals of oncology（2016）

引用4浏览0引用

加载更多

作者统计

#Papers: 55

#Citation: 1107

H-Index: 23

G-Index: 33

Sociability: 6

Diversity: 2

Activity: 0

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn